South America Epirubicin Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Dosage (10mg/Vial, 50mg/Vial, 100mg/Vial, and 200mg/Vial), Application (Breast Cancer, Liver Cancer, Bladder Cancer, and Others), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)        

No. of Pages: 91    |    Report Code: BMIRE00027264    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
South America Epirubicin Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        SAM Epirubicin Market – By Dosage

1.3.2        SAM Epirubicin Market – By Application

1.3.3        SAM Epirubicin Market – By Distribution Channel

1.3.4        SAM Epirubicin Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           SAM Epirubicin Market – Market Landscape

4.1         Overview

4.2         SAM PEST Analysis

4.3         Experts Opinion

5.           SAM Epirubicin Market– Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Prevalence of Cancer

5.1.2        Increasing Awareness Regarding Cancer

5.2         Market Restraints

5.2.1        Elevated Risk of Adverse Effects due to Epirubicin

5.3         Future Trends

5.3.1        Increase in Number of Cancer Research Programs

5.4         Impact Analysis

6.           Epirubicin Market– SAM Analysis

6.1         SAM Epirubicin Market Revenue Forecasts and Analysis

7.           SAM Epirubicin Market Analysis – By Dosage

7.1         Overview

7.2         SAM Epirubicin Market, by Dosage, 2022 & 2028 (%)

7.3mg/Vial

7.3.1        Overview

7.3.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

7.4mg/Vial

7.4.1        Overview

7.4.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

7.5mg/Vial

7.5.1        Overview

7.5.2mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

7.6mg/Vial

7.6.1        Overview

7.6.2 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

8.           SAM Epirubicin Market Analysis – By Application

8.1         Overview

8.2         SAM Epirubicin Market, by Application, 2022 & 2028 (%)

8.3         Breast Cancer

8.3.1        Overview

8.3.2        Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

8.4         Liver Cancer

8.4.1        Overview

8.4.2        Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

8.5         Bladder Cancer

8.5.1        Overview

8.5.2        Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

8.6         Others

8.6.1        Overview

8.6.2        Others Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

9.           SAM Epirubicin Market Analysis – By Distribution Channel

9.1         Overview

9.2         SAM Epirubicin Market, by Distribution Channel, 2022 & 2028 (%)

9.3         Hospital Pharmacies

9.3.1        Overview

9.3.2        Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

9.4         Retail Pharmacies

9.4.1        Overview

9.4.2        Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

9.5         Online Pharmacies

9.5.1        Overview

9.5.2        Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

10.        SAM Epirubicin Market – Country Analysis

10.1      Overview

10.1.2     SAM: Epirubicin Market, by Country, 2022 & 2028 (%)

10.1.2.1       Brazil: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

10.1.2.1.1       Overview

10.1.2.1.2       Brazil: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

10.1.2.1.3       Brazil: Epirubicin Market, by Dosage, 2019–2028 (USD Thousand)

10.1.2.1.4       Brazil: Epirubicin Market, by Application, 2019–2028 (USD Thousand)

10.1.2.1.5       Brazil: Epirubicin Market, by Distribution Channel, 2019–2028 (USD Thousand)

10.1.2.2       Argentina: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

10.1.2.2.1       Overview

10.1.2.2.2       Argentina: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

10.1.2.2.3       Argentina: Epirubicin Market, by Dosage, 2019–2028 (USD Thousand)

10.1.2.2.4       Argentina: Epirubicin Market, by Application, 2019–2028 (USD Thousand)

10.1.2.2.5       Argentina: Epirubicin Market, by Distribution Channel, 2019–2028 (USD Thousand)

10.1.2.3       Rest of SAM: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

10.1.2.3.1       Overview

10.1.2.3.2       Rest of SAM: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

10.1.2.3.3       Rest of SAM: Epirubicin Market, by Dosage, 2019–2028 (USD Thousand)

10.1.2.3.4       Rest of SAM: Epirubicin Market, by Application, 2019–2028 (USD Thousand)

10.1.2.3.5       Rest of SAM: Epirubicin Market, by Distribution Channel, 2019–2028 (USD Thousand)

11.        Industry Landscape

11.1      Overview

11.2      Growth Strategies

11.2.1     Overview

12.        Company Profiles

12.1      Pfizer Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Teva Pharmaceutical Industries Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Mylan N.V.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Hikma Pharmaceuticals PLC

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      Fresenius Kabi AG

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             SAM Epirubicin Market – Revenue and Forecast to 2028 (US$ Thousand)

Table 2.             Brazil: Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (USD Thousand)

Table 3.             Brazil: Epirubicin Market, by Application – Revenue and Forecast to 2028 (USD Thousand)

Table 4.             Brazil: Epirubicin Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Thousand)

Table 5.             Argentina: Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (USD Thousand)

Table 6.             Argentina: Epirubicin Market, by Application – Revenue and Forecast to 2028 (USD Thousand)

Table 7.             Argentina: Epirubicin Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Thousand)

Table 8.             Rest of SAM: Epirubicin Market, by Dosage – Revenue and Forecast to 2028 (USD Thousand)

Table 9.             Rest of SAM: Epirubicin Market, by Application – Revenue and Forecast to 2028 (USD Thousand)

Table 10.          Rest of SAM: Epirubicin Market, by Distribution Channel– Revenue and Forecast to 2028 (USD Thousand)

Table 11.          Recent Growth Strategies

Table 12.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           SAM Epirubicin Market Segmentation

Figure 2.           SAM Epirubicin Market, By Country

Figure 3.           SAM Epirubicin Market Overview

Figure 4.           SAM Epirubicin Market, By Dosage

Figure 5.           SAM Epirubicin Market, By Country

Figure 6.           SAM: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints on SAM Epirubicin Market

Figure 9.           SAM Epirubicin Market – Revenue Forecasts and Analysis

Figure 10.        SAM Epirubicin Market, by Dosage, 2022 & 2028 (%)

Figure 11.        SAM 10mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 12.        SAM 50mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 13.        SAM 100mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 14.        SAM 200 Mg/Vial Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 15.        SAM Epirubicin Market, by Application, 2022 & 2028 (%)

Figure 16.        SAM Breast Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 17.        SAM Liver Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 18.        SAM Bladder Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 19.        SAM Others Cancer Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 20.        SAM Epirubicin Market, by Distribution Channel, 2022 & 2028 (%)

Figure 21.        SAM Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 22.        SAM Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 23.        SAM Online Pharmacies Market Revenue and Forecast to 2028 (US$ Thousand)

Figure 24.        SAM: Epirubicin Market, by Key Country – Revenue (2022) (USD Thousand)

Figure 25.        SAM: Epirubicin Market, by Country, 2022 & 2028 (%)

Figure 26.        Brazil: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 27.        Argentina: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

Figure 28.        Rest of SAM: Epirubicin Market – Revenue and Forecast to 2028 (USD Thousand)

 

The List of Companies - South America Epirubicin Market

  1. Fresenius Kabi AG
  2. Hikma Pharmaceuticals PLC    
  3. Mylan N.V.    
  4. Pfizer Inc.    
  5. Teva Pharmaceutical Industries Ltd.